The poor outcome of double-hit DLBCL, defined by rearrangements affecting the MYC locus in combination with another breakpoint, mainly BCL2, appears to be the result of the combination of MYC and BCL2 overexpression [21–23]. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.